Blood test to predict coronary heart disease risk approved by FDA

December 16, 2014 4:05 PM

15 0

According to the Food and Drug Administration (FDA), the test - called the PLAC Test for Lp-PLA2 - has been cleared for use in both men and women with no history of heart disease, but studies have shown it is more accurate in predicting coronary heart disease risk (CHD) in women.

The test works by measuring the activity of Lp-PLA2 (lipoprotein-associated phospholipase A2) - an enzyme that is an indicator of vascular inflammation - in a blood sample. Vascular inflammation is a sign of plaque accumulation in the arteries, and this build-up of plaque can clog the arteries and c...

Read more

To category page